The Leader
in Critical Biological
Material Management


Market Solutions

Fisher BioServices is the industry leader in the management of critical biological materials to support the advancement of cell therapy, GMP biologics, and population-based public health research.

Cell Therapy

Learn More

Public Health Research

Learn More

GMP Biologics Management

Learn More


[Case Study] Scaling the
Advanced Therapy Supply Chain
October 25, 2017 I By: Rob Jones I Advanced Therapy

SOTIO had delivered early trials by using its in-house cryo-store and shipping under dry-ice to recipient centres. The plan was to scale this system into the PhIII trial. However, this proved to be impractical and too expensive.

This case study describes the use of dispersed storage and cold chain logistics, around a central manufacturing facility, to create a cost efficient and robust supply chain.

Supporting Services

Learning Center

Engaging content to enhance your knowledge of our services in action

Learn More

Stories From Our Clients

  • "Morris Animal Foundation’s Golden Retriever Lifetime study is a unique in that owners participate with their dogs and their regular clinical veterinarians. This has added a challenge of “site” training and monitoring. Fisher BioServices mitigated this challenge by implementing a process to check the volume of parent samples received prior to aliquoting, to assist with quality assurance and control with study protocols (appropriate sample volumes)."

     Erin Searfoss
    Study Director, Canine Lifetime Health Project, Morris Animal Foundation
  • "As Juventas’ Senior Director for all tasks associated  with CMC and supply of IP for early and late stage clinical studies Fisher BioService has figured prominently in that chain including labeling, finishing, storage and shipment of IP to clinical sites in the US.  My interactions with Fisher BioServices in this regard has been rather continuous in nature over the past 3+ years as JVS has evaluated both active and placebo IP in a variety of study indications, most importantly the gene therapy treatment of heart failure and peripheral artery disease.  Fisher BioServices has consistently provided excellent PM characterized by effective/timely communications in dealing with all requests and inquiries regardless of the hour of the day or day of the week.  I have found the team to be well experienced in devising and implementing solutions to problems that inevitably surface.  Most importantly the Fisher BioServices team has demonstrated a commitment to each of JVS’ projects as though the project was under their own umbrella."

    Mark D'Andrea
    Senior Director CMC and Quality, Juventas Therapeutics
  • Fisher Bioservices has been a superb service provider for us:

    ・Highly reliable storage/distribution services
    ・Compliant data recording and documentation system
    ・Very knowledgeable and experienced staff
    ・Responsive and collaborative management"

    - A top clinical stage biotechnology company
  • "We have contracted with Fisher BioServices for GMP storage of cell lines, both prokaryotic and mammalian, drug substance and drug product for nearly a decade. We have also utilized their shipping and receiving services countless times for local, pan USA and overseas shipments. The services provided by Fisher BioServices, including their Project Management and Business Development, has always been first rate. Any issues that occur are immediately transmitted to us and diligently pursued until resolved. We will continue to use the services provided by Fisher BioServices for the foreseeable future.”

    Terry Higgins
    Ph.D., Executive Director, Profectus BioSciences, Inc.
  • “During a highly complex and challenging study, the project management team at Fisher went above and beyond to ensure just-in-time appropriately blinded shipment of our drug (which was in limited supply), appropriate management and distribution of our study kits, and careful management of our inventory to ensure budgets were preserved.  The individual attention to detail from this experience is what has made me want to work with Fisher for future studies.”

    Liz LaPointe
    President, EndPointe Clinical Resources, Inc.

Join 8000 of your peers and subscribe to our blog for weekly updates on industry trends and new discoveries